Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)
Clinical trial NCT02155335 · COMPLETED
Trial details
- NCT number
- NCT02155335
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-01
- Primary completion
- 2015-10-05
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.